38255294|t|Cannabinerol (CBNR) Influences Synaptic Genes Associated with Cytoskeleton and Ion Channels in NSC-34 Cell Line: A Transcriptomic Study.
38255294|a|Cannabinoids are receiving great attention as a novel approach in the treatment of cognitive and motor disabilities, which characterize neurological disorders. To date, over 100 phytocannabinoids have been extracted from Cannabis sativa, and some of them have shown neuroprotective properties and the capacity to influence synaptic transmission. In this study, we investigated the effects of a less-known phytocannabinoid, cannabinerol (CBNR), on neuronal physiology. Using the NSC-34 motor-neuron-like cell line and next-generation sequencing analysis, we discovered that CBNR influences synaptic genes associated with synapse organization and specialization, including genes related to the cytoskeleton and ion channels. Specifically, the calcium, sodium, and potassium channel subunits (Cacna1b, Cacna1c, Cacnb1, Grin1, Scn8a, Kcnc1, Kcnj9) were upregulated, along with genes related to NMDAR (Agap3, Syngap1) and calcium (Cabp1, Camkv) signaling. Moreover, cytoskeletal and cytoskeleton-associated genes (Actn2, Ina, Trio, Marcks, Bsn, Rtn4, Dgkz, Htt) were also regulated by CBNR. These findings highlight the important role played by CBNR in the regulation of synaptogenesis and synaptic transmission, suggesting the need for further studies to evaluate the neuroprotective role of CBNR in the treatment of synaptic dysfunctions that characterize motor disabilities in many neurological disorders.
38255294	0	12	Cannabinerol	Chemical	-
38255294	14	18	CBNR	Chemical	-
38255294	95	101	NSC-34	CellLine	CVCL:D356
38255294	137	149	Cannabinoids	Chemical	MESH:D002186
38255294	220	252	cognitive and motor disabilities	Disease	MESH:D003072
38255294	273	295	neurological disorders	Disease	MESH:D009461
38255294	315	332	phytocannabinoids	Chemical	-
38255294	358	373	Cannabis sativa	Species	3483
38255294	542	558	phytocannabinoid	Chemical	-
38255294	560	572	cannabinerol	Chemical	-
38255294	574	578	CBNR	Chemical	-
38255294	615	621	NSC-34	CellLine	CVCL:D356
38255294	710	714	CBNR	Chemical	-
38255294	927	934	Cacna1b	Gene	12287
38255294	936	943	Cacna1c	Gene	12288
38255294	945	951	Cacnb1	Gene	12295
38255294	953	958	Grin1	Gene	14810
38255294	960	965	Scn8a	Gene	20273
38255294	967	972	Kcnc1	Gene	16502
38255294	974	979	Kcnj9	Gene	16524
38255294	1027	1032	NMDAR	Gene	14810
38255294	1034	1039	Agap3	Gene	213990
38255294	1041	1048	Syngap1	Gene	240057
38255294	1054	1061	calcium	Chemical	MESH:D002118
38255294	1063	1068	Cabp1	Gene	29867
38255294	1070	1075	Camkv	Gene	235604
38255294	1146	1151	Actn2	Gene	11472
38255294	1153	1156	Ina	Gene	226180
38255294	1158	1162	Trio	Gene	223435
38255294	1164	1170	Marcks	Gene	17118
38255294	1172	1175	Bsn	Gene	12217
38255294	1177	1181	Rtn4	Gene	68585
38255294	1183	1187	Dgkz	Gene	104418
38255294	1189	1192	Htt	Gene	15194
38255294	1217	1221	CBNR	Chemical	-
38255294	1277	1281	CBNR	Chemical	-
38255294	1425	1429	CBNR	Chemical	-
38255294	1450	1471	synaptic dysfunctions	Disease	MESH:C536122
38255294	1490	1508	motor disabilities	Disease	MESH:D009069
38255294	1517	1539	neurological disorders	Disease	MESH:D009461
38255294	Association	MESH:D002186	MESH:D009461
38255294	Association	MESH:D002186	MESH:D003072

